To determine whether the expression of HIF-1α and MDR1/P-gp in colon cancer patients differs, as well as the related sensitivity to chemotherapy, immunohistochemistry were employed to detect the expression of HIF-1α and P-gp in the tumor tissues of 120 patients with advanced colon carcinoma who received 5-FU-based chemotherapy. The gene discussed is ABCB1; the disease is malignant colon neoplasm.